Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Arthritis in United States

302 results

Sort By:

Knee Injections for Obese Patients With Knee Arthritis

Study ID: NCT06782529
Start Date: 2025-01-24
End Date: 2026-03-24
Study Type

Interventional

Study Phase

Phase4

No. of Participants

40

Intervention / Treatment

Triamcinolone Acetonide Low Dose

Triamcinolone Acetonide Standard Dose

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare

Study ID: NCT07145229
Start Date: 2025-08-26
End Date: 2026-06
Study Type

Interventional

Study Phase

Phase2

No. of Participants

380

Intervention / Treatment

ABP-745 Dose A

ABP-745 Dose B

Colchicine

Placebo

Sponsor

Atom Therapeutics Co., Ltd

Source: clinicaltrials.gov

Share:
Add to list

The Effect and Safety of Anti-inflammatories and Dextrose Prolotherapy Injections in Treating Knee Osteoarthritis

Study ID: NCT06911359
Start Date: 2025-03-31
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

68

Intervention / Treatment

Participants are given Ibuprofen 400 mg to take for 7 days on the day they receive a dextrose prolotherapy (DPT) injection. These procedures are repeated every 3-5 weeks for a total of 3 times.

Participants are given a placebo to take for 7 days on the day they receive a dextrose prolotherapy (DPT) injection. These procedures are repeated every 3-5 weeks for a total of 3 times.

Sponsor

David Grant U.S. Air Force Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Effects of Gait Retraining on Lower Extremity Biomechanics

Study ID: NCT03663790
Start Date: 2018-10-10
End Date: 2026-10-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

51

Intervention / Treatment

Foot Progression

Trunk Lean

Sponsor

George Mason University

Source: clinicaltrials.gov

Share:
Add to list

A Phase II Trial to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Pediatric and Adult Participants With Still's Disease

Study ID: NCT07203001
Start Date: 2025-11-03
End Date: 2029-05-24
Study Type

Interventional

Study Phase

Phase2

No. of Participants

20

Intervention / Treatment

Mithqakh

Sponsor

Novartis Pharmaceuticals

Source: clinicaltrials.gov

Share:
Add to list

A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Sjogren's Disease

Study ID: NCT07041099
Start Date: 2025-10-01
End Date: 2029-03-15
Study Type

Interventional

Study Phase

Phase1

No. of Participants

36

Intervention / Treatment

CLN-978

Sponsor

Cullinan Therapeutics Inc.

Source: clinicaltrials.gov

Share:
Add to list

Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMA

Study ID: NCT05754190
Start Date: 2023-06-20
End Date: 2026-05-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

800

Intervention / Treatment

SOMA pain manager smartphone application

Sponsor

Brown University

Source: clinicaltrials.gov

Share:
Add to list

A Phase 2b/3a Study to Evaluate the Efficacy and Safety of JointStem in Patients Diagnosed as Knee Osteoarthritis

Study ID: NCT04368806
Start Date: 2021-05-26
End Date: 2026-12-31
Study Type

Interventional

Study Phase

Phase3

No. of Participants

140

Intervention / Treatment

JointStem

Placebo Control

Sponsor

Nature Cell Co. Ltd.

Source: clinicaltrials.gov

Share:
Add to list

Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT

Study ID: NCT01962415
Start Date: 2014-02-04
End Date: 2027-11
Study Type

Interventional

Study Phase

Phase2

No. of Participants

100

Intervention / Treatment

Hydroxyurea

Alemtuzumab

Fludarabine

Melphalan

Thiotepa

Sponsor

Paul Szabolcs

Source: clinicaltrials.gov

Share:
Add to list

Reliability of Pupil Response to Acute Pain

Study ID: NCT02628314
Start Date: 2015-08-04
End Date: 2026-12
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

80

Intervention / Treatment
Sponsor

Wake Forest University Health Sciences

Source: clinicaltrials.gov

Share:
Add to list